Fatty acid transport across membranes: Relevance to nutrition and metabolic pathology

Annual Review of Nutrition

Volumn 22, Issue , 2002, Pages 383-415

  Hajri, Tahar ^a   Abumrad, Nada A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

CD36; CD36 null; CD36 overexpression; FAPBpm; FAT; FATP; Fatty acid; Membrane transport; SHR; Translocase

Indexed keywords

CARRIER PROTEIN; CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID;

ADIPOSE TISSUE; DIABETES MELLITUS; DIFFUSION; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HEART; INSULIN RESISTANCE; LIPID BILAYER; LIPID METABOLISM; MEMBRANE TRANSPORT; METABOLISM; MOUSE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SKELETAL MUSCLE; TISSUE DISTRIBUTION; TRANSPORT KINETICS;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; CELL MEMBRANE; FATTY ACIDS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE LIPIDS; MEMBRANE TRANSPORT PROTEINS; MODELS, ANIMAL; MUSCLE, SKELETAL; MYOCARDIUM; ORGANIC ANION TRANSPORTERS;

ANIMALIA;

EID: 0036401857     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.22.020402.130846     Document Type: Review

References (162)

1. Abumrad N, Coburn CT, Ibrahimi A. 1999. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta 1441:4-13
2. Abumrad N, Harmon C, Ibrahimi A. 1998. Membrane transport of long-chain fatty acids: Evidence for a facilitated process. J. Lipid Res. 39:2309-18
3. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268: 17665-68
4. Abumrad NA, Harmon CM, Barnela US, Whitesell RR. 1988. Insulin antagonism of catecholamine stimulation of fatty acid transport in the adipocyte. Studies on its mechanism of action. J. Biol. Chem. 263:14678-83
5. Abumrad NA, Park JH, Park CR. 1984. Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J. Biol. Chem. 259:8945-53
6. Abumrad NA, Perkins RC, Park JH, Park CR. 1981. Mechanism of long chain fatty acid permeation in the isolated adipocyte. J. Biol. Chem. 256:9183-91
7. Abumrad NA, Perry PR, Whitesell RR. 1986. Insulin antagonizes epinephrine activation of the membrane transport of fatty acids. Potential site for hormonal suppression of lipid mobilization. J. Biol. Chem. 261:2999-3001
8. Abumrad NA, Sfeir Z, Connelly MA, Coburn C. 2000. Lipid transporters: Membrane transport systems for cholesterol and fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 3: 255-6
9. Aitman TJ. 2001. CD36, insulin resistance, and coronary heart disease. Lancet 357:651-52
10. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, et al. 2000. Malaria susceptibility and CD36 mutation. Nature 405:1015-16
11. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, et al. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats [see comments]. Nat. Genet. 21:76-83
12. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA. 1995. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270:2367-71
13. Amri EZ, Teboul L, Vannier C, Grimaldi PA, Ailhaud G. 1996. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem. J. 314(Pt 2):541-46
14. Baillie AGS, Coburn CT, Abumrad NA. 1996. Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J. Membr. Biol. 153:75-81
15. Baldwin KM, Tipton CM. 1972. Work and metabolic patterns of fast and slow twitch skeletal muscle contracting in situ. Pflugers Arch. 334:345-56
16. Bastie C, Luquet S, Holst D, Jehl-Pietri C, Grimaldi PA. 2000. Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation. J. Biol. Chem. 275:38768-73
17. Berger J, Truppe C, Neumann H, Forss-Petter S. 1998. A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein genes with a distinct expression pattern. Biochem. Biophys. Res. Commun. 247:255-60
18. Berk PD, Bradbury M, Zhou SL, Stump D, Han NI. 1996. Characterization of membrane transport processes: Lessons from the study of BSP, bilirubin, and fatty acid uptake. Semin. Liver Dis. 16:107-20
19. Berk PD, Potter BJ, Sorrentino D, Stump D, Kiang CL, et al. 1990. Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. Ann. NY Acad. Sci. 585:379-85
20. Berk PD, Stump DD. 1999. Mechanisms of cellular uptake of long chain free fatty acids. Mol. Cell. Biochem. 192:17-31
21. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola LM. 1997. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J. Biol. Chem. 272:8830-35
22. Binnert C, Koistinen HA, Martin G, Andreelli F, Ebeling P, et al. 2000. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am. J. Physiol. Endocrinol. Metab. 279:E1072-E79
23. Boden G, Chen X, Ruiz J, White JV, Rossetti L. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-46
24. Bonen A, Dyck DJ, Ibrahimi A, Abumrad NA. 1999. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am. J. Physiol. Endocrinol. Metab. 276:E642-E49
25. Bonen A, Luiken JJ, Arumugam Y, Glatz JF, Tandon NN. 2000. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275:14501-8
26. Bull HA, Brickell PM, Dowd PM. 1994. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 351:41-44
27. Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, et al. 2001. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 44:444-52
28. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. 2001. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7:48-52
29. Chen M, Yang Y, Braunstein E, Georgeson KE, Harmon CM. 2001. Gut expression and regulation of FAT/CD36: Possible role in fatty acid transport in rat enterocytes. Am. J. Physiol. Endocrinol. Metab. 281:E916-E23
30. Chiba H, Yanai H, Fujiwara H, Matsuno K, Kobayashi K. 2001. CD36 deficiency and insulin resistance. Lancet 358:243 (discussion)
31. Christie GR, Hyde R, Hundal HS. 2001. Regulation of amino acid transporters by amino acid availability. Curr. Opin. Clin. Nutr. Metab. Care 4:425-31
32. Clinton SK, Giovannucci E. 1998. Diet, nutrition, and prostate cancer. Annu. Rev. Nutr. 18:413-40
33. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275:32523-29
34. Connelly MA, de la Llera-Moya M, Monzo P, Yancey PG, Drazul D, et al. 2001. Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain. Biochemistry 40:5249-59
35. Curtis BR, Aster RH. 1996. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 36:331-34
36. Cushman SW, Wardzala LJ. 1980. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem. 255:4758-62
37. DiRusso CC, Black PN. 1999. Long-chain fatty acid transport in bacteria and yeast. Paradigms for defining the mechanism underlying this protein-mediated process. Mol. Cell. Biochem. 192:41-52
38. Doggrell SA, Brown L. 1998. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc. Res. 39:89-105
39. Duplus E, Glorian M, Forest C. 2000. Fatty acid regulation of gene transcription. J. Biol. Chem. 275:30749-52
40. Dutta-Roy AK. 2000. Cellular uptake of long-chain fatty acids: Role of membrane-associated fatty-acid-binding/transport proteins. Cell. Mol. Life Sci. 57:1360-72
41. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, et al. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274:19055-62
42. Febbraio M, Hajjar DP, Silverstein RL. 2001. CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:785-91
43. Fitscher BA, Riedel HD, Young KC, Stremmel W. 1998. Tissue distribution and cDNA cloning of a human fatty acid transport protein (hsFATP4). Biochim. Biophys. Acta 1443:381-85
44. Frohnert BI, Hui TY, Bemlohr DA. 1999. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem. 274:3970-77
45. Fukuchi K, Nozaki S, Yoshizumi T, Hasegawa S, Uehara T, et al. 1999. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J. Nucl. Med. 40:239-43
46. Gao J, Serrero G. 1999. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J. Biol. Chem. 274:16825-30
47. Glatz JF, Storch J. 2001. Unravelling the significance of cellular fatty acid-binding proteins. Curr. Opin. Lipidol. 12:267-74
48. Goodman DS, Shiratori T. 1964. Fatty acid composition of human plasma lipoprotein fractions. J. Lipid Res. 5:307-13
49. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. 1992. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80:1105-15
50. Greenwalt DE, Scheck SH, Rhinehart-Jones T. 1995. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 96:1382-88
51. Griffin E, Re A, Hamel N, Fu C, Bush H, et al. 2001. A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat. Med. 7:840-46
52. Grimaldi PA. 2001. Fatty acid regulation of gene expression. Curr. Opin. Clin. Nutr. Metab. Care 4:433-37
53. Grimaldi PA, Teboul L, Gaillard D, Armengod AV, Amri EZ. 1999. Long chain fatty acids as modulators of gene transcription in preadipose cells. Mol. Cell. Biochem. 192:63-68
54. Guthmann F, Haupt R, Looman AC, Spener F, Rustow B. 1999. Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 277: L191-96
55. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, et al. 2001. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J. Biol. Chem. 276:23661-66
56. Hamilton JA, Johnson RA, Corkey B, Kamp F. 2001. Fatty acid transport: The diffusion mechanism in model and biological membranes. J. Mol. Neurosci. 16:99-108; discussion, pp. 51-57
57. Hamilton JA, Kamp F. 1999. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48:2255-69
58. Harmon CM, Abumrad NA. 1993. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J. Membr. Biol. 133:43-49
59. Heller A, Koch T, Schmeck J, van Ackem K. 1998. Lipid mediators in inflammatory disorders. Drugs 55:487-96
60. Hevener AL, Reichart D, Janez A, Olefsky J. 2001. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats. Diabetes 50: 2316-22
61. Deleted in proof
62. Hirsch D, Stahl A, Lodish HF. 1998. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA 95:8625-29
63. Ho M, White NJ. 1999. Molecular mechanisms of cytoadherence in malaria. Am. J. Physiol. Cell Physiol. 276:C1231-42
64. Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. 1991. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. USA 88:7844-48
65. Hwang EH, Taki J, Yasue S, Fujimoto M, Taniguchi M, et al. 1998. Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency. J. Nucl. Med. 39:1681-84
66. Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, et al. 1999. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274:26761-66
67. Ibrahimi A, Sfeir Z, Magharaie H, Amri EZ, Grimaldi P, Abumrad NA. 1996. Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport. Proc. Natl. Acad. Sci. USA 93:2646-51
68. Iizuka Y, Gotoda T, Ishibashi S, Yamada N. 2001. CD36 deficiency and insulin resistance. Lancet 358:243 (discussion)
69. Ito K, Sugihara H, Tanabe T, Zen K, Hikosaka T, et al. 2001. A patient with type I CD36 deficiency whose myocardium accumulated 123I-BMIPP after 4 years. Ann. Nucl. Med. 15:271-76
70. Jump DB. 2001. The biochemistry of N3-polyunsaturated fatty acids. J. Biol. Chem. Published Dec. 17, 2001 as 10.1074/jbc.R100062200
71. Kamp F, Hamilton JA, Westerhoff HV. 1993. Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry 32:11074-86
72. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, et al. 1995. Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline90→ serine) in CD36 cDNA accounts for CD36 deficiency. J. Clin. Invest. 95:1040-46
73. Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, et al. 1996. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler. Thromb. Vasc. Biol. 16:1026-32
74. Kashiwagi H, Tomiyama Y, Nozaki S, Kiyoi T, Tadokoro S, et al. 2001. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: Identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum. Genet. 108:459-66
75. Kerkhoff C, Sorg C, Tandon NN, Nacken W. 2001. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 40:241-48
76. Kiens B, Kristiansen S, Jensen P, Richter EA, Turcotte LP. 1997. Membrane associated fatty acid binding protein (FABPpm) in human skeletal muscle is increased by endurance training. Biochem. Biophys. Res. Commun. 231:463-65
77. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA 98:7522-27
78. Kleinfeld AM. 2000. Lipid phase fatty acid flip-flop: Is it fast enough for cellular transport? J. Membr. Biol. 175:79-86
79. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, et al. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 42:113-16
80. Liang X, Nazarian A, Erdjument-Bromage H, Bornmann W, Tempst P, Resh MD. 2001. Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J. Biol. Chem. 276:30987-94
81. Lobo MV, Huerta L, Ruiz-Velasco N, Teixeiro E, de la Cueva P, et al. 2001. Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract: Towards the identification of receptors mediating the intestinal absorption of dietary lipids. J. Histochem. Cytochem. 49:1253-60
82. Luiken JJ, Glatz JF, Bonen A. 2000. Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle. Can. J. Appl. Physiol. 25:333-52
83. Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A, Glatz JF. 1999. Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins. Lipids 34(Suppl):S169-75
84. Luiken JJ, van Nieuwenhoven FA, America G, van der Vusse GJ, Glatz JF. 1997. Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: Involvement of sarcolemmal proteins. J. Lipid Res. 38:745-58
85. Man MZ, Hui TY, Schaffer JE, Lodish HF, Bernlohr DA. 1996. Regulation of the murine adipocyte fatty acid transporter gene by insulin. Mol. Endocrinol. 10:1021-28
86. Martin G, Poirier H, Hennuyer N, Crombie D, Fruchart JC, et al. 2000. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimerselective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J. Biol. Chem. 275: 12612-18
87. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272:28210-17
88. Melki SA, Abumrad NA. 1992. Glycerolipid synthesis in isolated adipocytes: Substrate dependence and influence of norepinephrine. J. Lipid Res. 33:669-78
89. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C. 1998. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am. J. Physiol. Endocrinol. Metab. 274:E210-E17
90. Memon RA, Fuller J, Moser AH, Smith PJ, Grunfeld C, Feingold KR. 1999. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes 48:121-27
91. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, et al. 2000. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021-31
92. Miao WM, Vasile E, Lane WS, Lawler J. 2001. CD36 associates with CD9 and integrins on human blood platelets. Blood 97:1689-96
93. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. 2001. CD36 deficiency associated with insulin resistance. Lancet 357:686-87
94. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. 1998. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J. Biol. Chem. 273:16710-14
95. Mutanen M, Freese R. 2001. Fats, lipids and blood coagulation. Curr. Opin. Lipidol. 12:25-29
96. Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP. 2000. CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann. NY Acad. Sci. 902:128-31; discussion, pp. 31-33
97. Nisoli E, Carruba MO, Tonello C, Macor C, Federspil G, Vettor R. 2000. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes 49:319-24
98. Perseghin G, Ghosh S, Gerow K, Shulman GI. 1997. Metabolic defects in lean non-diabetic offspring of NIDDM parents: A cross-sectional study. Diabetes 46:1001-9
99. Petrie JR, Collison M, Connell JM, Gould GW, Dominiczak AF. 2001. CD36 deficiency and insulin resistance. Lancet 358:242-43 (discussion)
100. Poirier H, Degrace P, Niot I, Bernard A, Besnard P. 1996. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur. J. Biochem. 238:368-73
101. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, et al. 2001. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27:156-58
102. Rader DJ, Dugi KA. 2000. The endothelium and lipoproteins: Insights from recent cell biology and animal studies. Semin. Thromb. Hemost. 26:521-28
103. Razani B, Combs TP, Wang XB, Frank PG, Park DS, et al. 2001. Caveolin-1 deficient mice are lean, resistant to diet-induced obesity, and show hyper-triglyceridemia with adipocyte abnormalities. J. Biol. Chem. Published Dec. 5, 2001 as 10.1074/jbc.M110970200
104. Richieri GV, Anel A, Kleinfeld AM. 1993. Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADI-FAB. Biochemistry 32:7574-80
105. Richieri GV, Kleinfeld AM. 1995. Unbound free fatty acid levels in human serum. J. Lipid Res. 36:229-40
106. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, et al. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97:2859-65
107. Savill J, Hogg N, Ren Y, Haslett C. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-22
108. Schaap FG, Hamers L, Van der Vusse GJ, Glatz JF. 1997. Molecular cloning of fatty acid-transport protein cDNA from rat. Biochim. Biophys. Acta 1354:29-34
109. Deleted in proof
110. Schaffer JE, Lodish HF. 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein [see comments]. Cell 79:427-36
111. Schimmel RJ, Goodman HM. 1971. Efflux of free fatty acids from adipose tissue. Am. J. Physiol. 221:118-22
112. Schwieterman W, Sorrentino D, Potter BJ, Rand J, Kiang CL, et al. 1988. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc. Natl. Acad. Sci. USA 85:359-63
113. Serrero G, Frolov A, Schroeder F, Tanaka K, Gelhaar L. 2000. Adipose differentiation related protein: Expression, purification of recombinant protein in Escherichia coli and characterization of its fatty acid binding properties. Biochim. Biophys. Acta 1488:245-54
114. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N. 1999. CD36 antisense expression in 3T3-F442A preadipocytes. Mol. Cell. Biochem. 192:3-8
115. Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, et al. 2001. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol. Pharmacol. 59:765-73
116. Sorrentino D, Robinson RB, Kiang CL, Berk PD. 1989. At physiologic albumin/-toleate concentrations oleate uptake by isolated hepatocytes, cardiac myocytes, and adipocytes is a saturable function of the unbound oleate concentration. Uptake kinetics are consistent with the conventional theory. J. Clin. Invest. 84:1325-33
117. Sorrentino D, Stump D, Potter BJ, Robinson RB, White R, et al. 1988. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J. Clin. Invest. 82:928-35
118. Sorrentino D, Stump DD, Van Ness K, Simard A, Schwab AJ, et al. 1996. Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate. Am. J. Physiol. Gastrointest. Liver Physiol. 270:G385-92
119. Spector AA, John K, Fletcher JE. 1969. Binding of long-chain fatty acids to bovine serum albumin. J. Lipid Res. 10:56-67
120. Spector AA, Steinberg D. 1965. The utilization of unesterified palmitate by Ehrlich ascites tumor cells. J. Biol. Chem. 240: 3747-53
121. Spitsberg VL, Matitashvili E, Gorewit RC. 1995. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur. J. Biochem. 230:872-78
122. Stahl A, Gimeno RE, Tartaglia LA, Lodish HF. 2001. Fatty acid transport proteins: A current view of a growing family. Trends Endocrinol. Metab. 12:266-73
123. Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, et al. 1999. Identification of the major intestinal fatty acid transport protein. Mol. Cell. 4:299-308
124. Stals HK, Top W, Declercq PE. 1994. Regulation of triacylglycerol synthesis in permeabilized rat hepatocytes. Role of fatty acid concentration and diacylglycerol acyltransferase. FEBS Lett. 343:99-102
125. Steinberg GR, Dyck DJ, Calles-Escandon J, Tandon NN, Luiken JJ, et al. 2001. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J. Biol. Chem. Published Nov. 29, 2001 as 10.1074/jbc.M107683200
126. Storch J, Lechene C, Kleinfeld AM. 1991. Direct determination of free fatty acid transport across the adipocyte plasma membrane using quantitative fluorescence microscopy. J. Biol. Chem. 266: 13473-76
127. Stremmel W. 1988. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J. Clin. Invest. 81:844-52
128. Stremmel W. 1988. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Invest. 82:2001-10
129. Stremmel W, Berk PD. 1986. Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc. Natl. Acad. Sci. USA 83:3086-90
130. Stremmel W, Lotz G, Strohmeyer G, Berk PD. 1985. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J. Clin. Invest. 75:1068-76
131. Stremmel W, Strohmeyer G, Berk PD. 1986. Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc. Natl. Acad. Sci. USA 83: 3584-88
132. Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD. 1985. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. USA 82:4-8
133. Stremmel W, Theilmann L. 1986. Selective inhibition of long-chain fatty acid uptake in short-term cultured rat hepatocytes by an antibody to the rat liver plasma membrane fatty acid-binding protein. Biochim. Biophys. Acta 877:191-97
134. Stuhlsatz-Krouper SM, Bennett NE, Schaffer JE. 1998. Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. J. Biol. Chem. 273:28642-50
135. Stump DD, Fan X, Berk PD. 2001. Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake. J. Lipid Res. 42:509-20
136. Stump DD, Zhou SL, Berk PD. 1993. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am. J. Physiol. 265:G894-902
137. Sukhotnik I, Gork AS, Chen M, Drongowski RA, Coran AG, Harmon CM. 2001. Effect of low fat diet on lipid absorption and fatty-acid transport following bowel resection. Pediatr. Surg. Int. 17:259-64
138. Suzuki K, Kono T. 1980. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc. Natl. Acad. Sci. USA 77:2542-45
139. Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, et al. 2001. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J. Lipid Res. 42:751-59
140. Tanaka T, Okamoto F, Sohmiya K, Kawamura K. 1997. Lack of myocardial iodine-123 15-(p-iodiphenyl)-3-R,S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality - CD36 deficiency and hypertrophic cardiomyopathy. Jpn. Circ. J. 61:724-25
141. Tao N, Wagner SJ, Lublin DM. 1996. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J. Biol. Chem. 271:22315-20
142. Thorne RF, Marshall JF, Shafren DR, Gibson PG, Hart IR, Burns GF. 2000. The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36. J. Biol. Chem. 275:35264-75
143. Tontonoz P, Nagy L. 1999. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: Implications for cardiovascular disease. Curr. Opin. Lipidol. 10:485-90
144. Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B. 2001. Peroxisome proliferator-activated receptors: From transcriptional control to clinical practice. Curr. Opin. Lipidol. 12:245-54
145. Trotter PJ, Ho SY, Storch J. 1996. Fatty acid uptake by Caco-2 human intestinal cells. J. Lipid Res. 37:336-46
146. Turcotte LP, Petry C, Kiens B, Richter EA. 1998. Contraction-induced increase in Vmax of palmitate uptake and oxidation in perfused skeletal muscle. J. Appl. Physiol. 84:1788-94
147. Turcotte LP, Richter EA, Kiens B. 1992. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am. J. Physiol. Endocrinol. Metab. 262:E791-99
148. Turcotte LP, Srivastava AK, Chiasson JL. 1997. Fasting increases plasma membrane fatty acid-binding protein (FABP(PM)) in red skeletal muscle. Mol. Cell. Biochem. 166:153-58
149. Uchiyama A, Aoyama T, Kamijo K, Uchida Y, Kondo N, et al. 1996. Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J. Biol. Chem. 271:30360-65
150. van der Flier A, Sonnenberg A. 2001. Function and interactions of integrins. Cell Tissue Res. 305:285-98
151. van der Lee KA, Vork MM, De Vries JE, Willemsen PH, Glatz JF, et al. 2000. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J. Lipid Res. 41:41-47
152. Van Nieuwenhoven FA, Verstijnen CP, Abumrad NA, Willemsen PH, Van Eys GJ, et al. 1995. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun. 207:747-52
153. Vorum H, Brodersen R, Kragh-Hansen U, Pedersen AO. 1992. Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim. Biophys. Acta 1126:135-42
154. Vosper H, Patel L, Graham TL, Khoudoli GA, Hill A, et al. 2001. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J. Biol. Chem. 276:44258-65
155. Watkins PA, Pevsner J, Steinberg SJ. 1999. Human very long-chain acyl-CoA synthetase and two human homologs: Initial characterization and relationship to fatty acid transport protein. Prostaglandins Leukot. Essent. Fatty Acids 60: 323-28
156. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, et al. 2001. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J. Invest. Dermatol. 116:702-12
157. Whitesell RR, Abumrad NA. 1985. Increased affinity predominates in insulin stimulation of glucose transport in the adipocyte. J. Biol. Chem. 260:2894-99
158. Yanai H, Chiba H, Fujiwara H, Morimoto M, Abe K, et al. 2000. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb. Haemost. 84:436-41
159. Yehuda S, Rabinovitz S, Mostofsky DI. 1999. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 56:565-70
160. Zhou SL, Stump D, Isola L, Berk PD. 1994. Constitutive expression of a saturable transport system for non-esterified fatty acids in Xenopus laevis oocytes. Biochem. J. 297(Pt 2):315-19
161. Zhou SL, Stump D, Sorrentino D, Potter BJ, Berk PD. 1992. Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein. J. Biol. Chem. 267:14456-61
162. Zhou SL, Gordon RE, Bradbury M, Stump D, Kiang CL, Berk PD. 1998. Ethanol upregulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology 27:1064-74